Hemp Synergistics has been working hand in hand with well-known cannabis legalization advocate Rinus Beintema and his non-profit group Suver Nuver to develop condition-specific custom-cannabinoid treatments as a user-friendly successor to cannabis oil. The maximum THC percentage for CBD products is 0.05 percent in the Netherlands, considerably lower than the 0.2 percent found in the rest of Europe. Beintema needed an end-product guaranteed to maintain legal compliance and set out to find an advanced laboratory and manufacturer to assist. Enter Hemp Synergistics, an innovative Pittsburgh-based biotechnology company that specializes in extracting, isolating, and standardizing the active molecules in hemp.
The company had already conquered absorption of these substances, referred to as “bioavailability“, by preventing the body from breaking them down in the digestive process. This solves the problem by encapsulating the active hemp molecules by utilizing a patent-pending process and product known as Bio-Dri™, which causes a “Trojan Horse Effect” allowing the body to pass these substances by protecting the active ingredients from destructive enzymes to provide an outstanding absorption rate.
